| Literature DB >> 22530940 |
Jeongyoon Lee1, Walter G Bottje, Byung-Whi Kong.
Abstract
BACKGROUND: Infectious laryngotracheitis virus (ILTV; gallid herpesvirus 1) infection causes high mortality and huge economic losses in the poultry industry. To protect chickens against ILTV infection, chicken-embryo origin (CEO) and tissue-culture origin (TCO) vaccines have been used. However, the transmission of vaccine ILTV from vaccinated- to unvaccinated chickens can cause severe respiratory disease. Previously, host cell responses against virulent ILTV infections were determined by microarray analysis. In this study, a microarray analysis was performed to understand host-vaccine ILTV interactions at the host gene transcription level.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22530940 PMCID: PMC3353197 DOI: 10.1186/1471-2164-13-143
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Morphology of chicken embryo lung cells infected by vaccine ILTV and the expression of ILTV genes. (A) Cell morphology and cytopathic effect development at 0, 1, 2, 3 and 4 dpi are displayed by phase-contrast microscopic images at 200 × magnification. (B) ILTV gene expression for UL35 and US5 was determined by RT-PCR. Chicken GAPDH (chGAPDH) was used as an endogenous control.
Primers for qPCR
| GenBank | Forward Primer | Reverse Primer |
|---|---|---|
| GGCACCAACTTGCTACCACA | GCTGCAAGAGCTGCCATTAG | |
| CCAGCTACATCTCCCACCTG | TCTGTTTGGGCTGGGAGTTC | |
| GTACAACCACGTTGGGCAGA | CTCTCGCGTTTCCTTTGAGG | |
| TTGTGGCCTACCCCAGATGT | GGATGGGACTTTCCAGAGCA | |
| CTGTTTCCTGACCGCAGTTC | AGCACAAACTCCGCCATTTT | |
| CCTGTGCAAGGTGTCCAGTG | CCCAATGGCCATACAGTTCA | |
| GCAAAGCACCATCCCAAATA | TAT TGAGGCGCTGACTCCTG | |
| CTGGGATCCCTCCAGAGCTA | CCATTCACTGGAGCACCAAA | |
| CGAGGCCATCAACTTCCTTC | TCCACATGACGCACATACCC | |
| CCAGCTGTCCTCCTTGGAAT | AGGGAGAGGAAGACGTGCTG | |
| GGCCTTGAATGACCATCATGT | AACAGCAGCAGGAACAGTGC | |
| CGCGCTCTACGACTACATGC | CTGGGTGGTGATCTCGGTCT | |
| TGCAGCACTGAGACCTGGAT | CAGTTGCTGCGGATGAAGTC | |
| TTTTGGCTACCAGTCCAGCA | TTCGCAAGTGTTCCCCAGTA | |
| TGCTCCCCTGAGTACTGGAA | GCCTCTGTGGGTTCAGGATT | |
| TCCCACTGAGCAGCTTCTGTA | CCAGAGAGATATCCGCAGCA | |
| GGTGCTGACTTTCGCCTTGT | GCCTGGTGATGAGGTTGATG | |
| CCACCTGAGAAAAGCGACCT | ACATCGACCTCTGCCAACCT | |
Validation of gene expression between microarray and qPCR
| GenBank | Symbol | Fold Change (Microarray/qPCR) | |||
|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 4 | ||
| SLC37A2 | 1.2/1.3 | 2.1/2.6 | 3.3/3.7 | 3.9/4.5 | |
| THBS2 | 1.5/1.8 | 2.0/2.5 | 2.8/2.8 | 3.3/3.3 | |
| C1QTNF3 | -0.2/0.1 | 1.2/2.0 | 1.9/2.5 | 2.7/3.4 | |
| CAPSL | 2.3/3.0 | 2.6/3.7 | 3.2/4.3 | 3.5/4.4 | |
| CYTL1 | 1.0/1.7 | 1.4/2.8 | 2.7/4.2 | 2.9/4.4 | |
| ALDOB | 0.7/1.1 | 1.0/1.7 | 2.1/2.2 | 2.7/2.5 | |
| MXRA5 | 0.8/1.5 | 1.7/3.0 | 2.5/3.7 | 3.0/4.4 | |
| EGLN3 | -2.7/-2.0 | -2.3/-1.9 | -1.7/-1.4 | -1.3/-0.9 | |
| VIPR2 | 1.7/2.0 | 2.3/2.9 | 2.9/3.6 | 3.1/5.1 | |
| CLEC3B | 0.2/1.0 | 0.4/2.2 | 1.3/2.4 | 1.4/3.1 | |
| NPY | -0.4/-0.3 | -0.9/-0.6 | -1.5/-0. 9 | -1.7/-1.3 | |
| LUM | 1.2/1.6 | 1. 5/2.3 | 1.9/2.5 | 2.5/3.2 | |
| PTGS2 | -0.6/-0.6 | -0.8/-0.3 | -0.2/-0.4 | 0.7/1.2 | |
| HMGCR | 0.4/0.4 | 0.2/0.6 | -0.5/-0.3 | -0.9/-0.6 | |
| TMEM116 | 0.0/0.0 | -0.3/0.3 | -0.3/-0.1 | -1.3/-0.7 | |
| FST | 1.3/1.0 | 0.6/1.2 | 0.6/0.6 | -0.3/0.2 | |
| ANPEP | -0.1/-1.2 | -0.5/0.5 | -0.6/0.4 | -1.4/-0.2 | |
| SCX | 1.1/0.2 | 1.4/-0.6 | 1.8/0.1 | 2.3/-0.6 | |
Figure 2Functional groups of differentially expressed genes. Out of 75 functional groups, the top 20 groups considered based on gene number were displayed.
Figure 3The 10 most differentially expressed genes in ILTV vaccine infection. The blue, red, green and purple bars represent 1 dpi, 2 dpi, 3 dpi, and 4 dpi for vaccine ILTV infections, respectively. Mean ± standard deviation value of log2 fold change among four dpi time points are indicated under the gene name.
Functions of the 10 most differentially expressed genes in ILTV vaccine infection
| Symbol | Functions |
|---|---|
| C1QTNF3 (CTRP3) | • C1q and tumor necrosis factor related protein 3, a. k. a. CTRP3. |
| AQP5 | • Aquaporin 5, a water channel protein. |
| CCK | • Cholecystokinin |
| SPINK5 | • Serine peptidase inhibitor, Kazal type 5 or chicken ovomucoid |
| THBS2 | • Thrombospondin 2, a potent inhibitor of tumor growth and angiogenesis and a matricellular glycoprotein which mediates cell-to-cell interaction [ |
| PPIF | • Peptidylprolyl isomerase F, one of the peptidyl-prolyl cis-trans isomerase (PPIase) family proteins and a member of the mitochondrial permeability transition (PT) pore in the inner mitochondrial membrane. |
| VLDVR | • Very low density lipoprotein/vitellogenin receptor |
| NMU | • Neuromedin U, a multifunctional neuropeptide |
| ADAM28 | • A disintegrin and metalloproteinase (ADAM) domain 28. |
| FST | • Follistatin |
Figure 4Network #1 at 1dpi. Symbols of functions for each molecule used to generate the molecular network are displayed. The green indicates down-regulation, while the red depicts up-regulation. White symbols indicate neighboring genes that are functionally associated but not included in the differentially expressed gene list. The intensity of color represents the average of log2 fold change in a given population. The numbers below the color change bar denote log2 values. Symbols for each molecule are presented according to molecular functions and type of interactions.
Figure 5Four differently expressed genes in both virulent strain and vaccine ILTV infections. Relative expression was compared for four genes between vaccine ILTV infection and that reported for virulent strain ILTV [25]. The blue, red, green and purple bars represent virulent strain at 1 dpi, virulent strain at 3 dpi, vaccine at 1 dpi, and vaccine at 3 dpi for ILTV infections, respectively.